Matrix metalloproteinase-1 genepolymorphism is associated with the prognosis of hepatocellular carcinoma in Egyptian population

This study aimed to examine the relationship between the gene polymorphism ofMMP-1and the prognosis of hepatitisCvirus (HCV)-related hepatocellular carcinoma (HCC) in Egyptian population.Methods: The study enrolled 180 Egyptian individuals classified into 3 groupsGroup I: consists of 60 apparently healthy individuals served as control Group II: consists of 60 individuals diagnosed with HCV Group III: consists of 60 individuals diagnosed with HCC.Gene polymorphism of MMP-1 -16071G/2G using restriction fragment length polymorphism(RFLP) for amplified genomicDNA was analyzed.Results: In HCC prognosis, MMP-12G carriers hadhigher probability of developing HCC when compared to healthy individuals.Conclusion:MMP-1 2G allele may bea cooperative risk factor for poor prognosis in HCC patients, suggesting that further studies with larger sample size should be investigated to ensure that this gene polymorphism might be a potential marker for predicting the prognosis of HCC patients in Egyptian patients.

[1]  O. Hammam,et al.  Expression of Matrix Metalloproteinase 1(MMP1) in HepatoCellular Carcinoma (HCC): Immunohistochemical and Biochemical Studies , 2013 .

[2]  Yangde Zhang,et al.  Hepatocellular Carcinoma: Focus on Different Aspects of Management , 2012, ISRN oncology.

[3]  T. Vlaykova,et al.  Polymorphisms of Matrix Metalloproteinases (MMP) in COPD , 2012 .

[4]  A. Tardón,et al.  Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival , 2012, BMC Cancer.

[5]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[6]  D. Hommes,et al.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer. , 2011, World journal of gastrointestinal oncology.

[7]  Valerie M. Weaver,et al.  The extracellular matrix at a glance , 2010, Journal of Cell Science.

[8]  Bo Peng,et al.  Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. , 2010, Mutagenesis.

[9]  A. Berdeli,et al.  Clinical and genetic aspects of Turkish hepatocellular carcinoma patients: Results of a single center study , 2010 .

[10]  I. Yuasa,et al.  The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. , 2010, Internal medicine.

[11]  N. Abdel-Hamid.  Recent insights on risk factors of hepatocellular carcinoma. , 2009, World journal of hepatology.

[12]  L. Rodrigo,et al.  Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  D. Christiani,et al.  Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. , 2009, Carcinogenesis.

[14]  M. Motovali-Bashi,et al.  The Influence of Interstitial Collagenas-1 Genotype Polymorphism on Colorectal Cancer Risk in Iranian Population , 2008, Cancer investigation.

[15]  J. Kim,et al.  Clinical implications of matrix metalloproteinase‐1, ‐3, ‐7, ‐9, ‐12, and plasminogen activator inhibitor‐1 gene polymorphisms in colorectal cancer , 2007, Journal of gastroenterology and hepatology.

[16]  Gangqiao Zhou,et al.  Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk , 2007, Gut.

[17]  D. Wakefield,et al.  The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer , 2007, British Journal of Cancer.

[18]  I. Yuasa,et al.  Association of functional gene polymorphisms of matrix metalloproteinase (MMP)‐1, MMP‐3 and MMP‐9 with the progression of chronic liver disease , 2005, Journal of gastroenterology and hepatology.

[19]  S. Ye,et al.  Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. , 2000, Matrix biology : journal of the International Society for Matrix Biology.